Trial intelligence / Profile preview

Pimecrolimus 1% cream for seborrhoeic dermatitis

2006-003984-30Phase 2Completed

Sponsor
Novartis
Start
Oct 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in seborrheic dermatitis (SD) comparing Pimecrolimus 1% cream with Vehicle control (2 arms). Primary endpoint: overall clearance. Started Oct 2006; status: completed.

02

Drugs

pimecrolimus
03

Conditions

seborrheic dermatitis (SD)

Beyond the preview

Go deeper on 2006-003984-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003984-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call